- Home
- EOLS vs MOV Comparison
EOLS vs MOV Comparison
Compare EOLS & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOLS
- MOV
- Stock Information
- Founded
- EOLS 2012
- MOV 1961
- Country
- EOLS United States
- MOV United States
- Employees
- EOLS N/A
- MOV N/A
- Industry
- EOLS Biotechnology: Pharmaceutical Preparations
- MOV Consumer Specialties
- Sector
- EOLS Health Care
- MOV Consumer Discretionary
- Exchange
- EOLS Nasdaq
- MOV Nasdaq
- Market Cap
- EOLS 406.9M
- MOV 339.1M
- IPO Year
- EOLS 2018
- MOV 1993
- Fundamental
- Price
- EOLS $6.50
- MOV $19.61
- Analyst Decision
- EOLS Strong Buy
- MOV Strong Buy
- Analyst Count
- EOLS 4
- MOV 1
- Target Price
- EOLS $21.25
- MOV $31.50
- AVG Volume (30 Days)
- EOLS 1.0M
- MOV 154.2K
- Earning Date
- EOLS 11-05-2025
- MOV 08-28-2025
- Dividend Yield
- EOLS N/A
- MOV 7.15%
- EPS Growth
- EOLS N/A
- MOV N/A
- EPS
- EOLS N/A
- MOV 0.77
- Revenue
- EOLS $277,941,000.00
- MOV $655,597,000.00
- Revenue This Year
- EOLS $13.68
- MOV $1.98
- Revenue Next Year
- EOLS $27.96
- MOV N/A
- P/E Ratio
- EOLS N/A
- MOV $25.39
- Revenue Growth
- EOLS 17.15
- MOV 0.79
- 52 Week Low
- EOLS $5.71
- MOV $12.85
- 52 Week High
- EOLS $17.82
- MOV $22.20
- Technical
- Relative Strength Index (RSI)
- EOLS 44.82
- MOV 62.78
- Support Level
- EOLS $6.08
- MOV $18.60
- Resistance Level
- EOLS $6.36
- MOV $19.40
- Average True Range (ATR)
- EOLS 0.22
- MOV 0.43
- MACD
- EOLS 0.04
- MOV -0.11
- Stochastic Oscillator
- EOLS 71.96
- MOV 59.78
About EOLS Evolus Inc.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.